FDA Investigating Death Due to Neutralizing Antibodies to ADAMTS13... Since approval, the Food and Drug Administration (FDA) has received postmarketing reports of neutralizing antibodies to ADAMTS13, including one death, in congenital thrombotic thrombocytopenic purpura...

Hello #benignheme community. I am curious of the recent #FDA investigation about #Adzynma influences you to make any changes and what were those changes in your recommendation about the product www.fda.gov/vaccines-blo...